SEARCH

SEARCH BY CITATION

References

  • Adjuvant! Online. Decision making tools for health care professionals. http://www.adjuvantonline.com (accessed on 1 May 2010).
  • Anderson BO, Shyyan R, Eniu A et al. (2006) Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. The Breast Journal 12(Suppl 1), S3S15.
  • Anderson BO, Cazap E, El Saghir NS et al. (2011) Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus 2010. The Lancet Oncology 12, 387398.
  • Bland KI, Menck HR, Scott-Conner CE et al. (1998) The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 83, 12621273.
  • Bobo JK, Lee NC & Thames SF (2000) Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. Journal of the National Cancer Institute 92, 971976.
  • Broekx S, Den Hond E, Torfs R et al. (2011) The costs of breast cancer prior to and following diagnosis. The European Journal of Health Economics 12, 311317.
  • Brown M, Goldie S, Draisma G, Harford J & Lipscomb J (2006) Disease control priorities in developing countries. In: Health Service Interventions for Cancer Control in Developing Countries, 2nd edn (eds D Jamison, J Breman, A Measham, G Alleyne, M Claeson, D Evans, P Jha, A Mills & P Musgrove) World Bank, Washington, DC, pp. 569589.
  • Clegg-Lamptey JN, Aduful HK, Yarney J et al. (2009a) Profile of breast diseases at a self-referral clinic in Ghana. West African Journal of Medicine 28, 114117.
  • Clegg-Lamptey JN, Dakubo JC & Attobra YN (2009b) Psychosocial aspects of breast cancer treatment in Accra, Ghana. East African Medical Journal 86, 348353.
  • Connor SR, Pyenson B, Fitch K, Spence C & Iwasaki K (2007) Comparing hospice and nonhospice patient survival among patients who die within a three-year window. Journal of Pain and Symptom Management 33, 238246.
  • Devi BC, Tang TS & Corbex M (2007) Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. Annals of Oncology 18, 11721176.
  • Devi BC, Tang TS & Corbex M (2008) Setting up home-based palliative care in countries with limited resources: a model from Sarawak, Malaysia. Annals of Oncology 19, 20612066.
  • Duffy SW & Gabe R (2005) What should the detection rates of cancers be in breast screening programmes? British Journal of Cancer 92, 597600.
  • Edejer T-TT, Baltusssen R, Adam T et al. (2003) WHO Guide to Cost-Effectiveness Analysis. World Health Organization, Geneva.
  • Elmore JG, Barton MB, Moceri VM et al. (1998) Ten-year risk of false positive screening mammograms and clinical breast examinations. New England Journal of Medicine 338, 10891096.
  • Engel J, Baumert J, Dirschedl P, Sauer H & Hölzel D (2000) Effectiveness of self-examination, palpation and mammography for the early detection of breast cancer: first results of the Munich Field Study, [in German]. Geburtsh Frauenheilk 60, 155164.
  • Evans DB, Lim SS, Adam T & Edejer TT (2005) Evaluation of current strategies and future priorities for improving health in developing countries. BMJ 331, 14571461.
  • Fletcher SW & Elmore JG (2005) False-positive mammograms – can the USA learn from Europe? Lancet 365, 78.
  • Flobbe K, Van Linden Der ES, Kessels AG & Van Engelshoven JM (2001) Diagnostic value of radiological breast imaging in a non-screening population. International Journal of Cancer 92, 616618.
  • Fracheboud J, De Gelder R & Van Ineveld BM (2009) National Evaluation of Breast Cancer Screening in the Netherlands 1990–2007. Twelfth evaluation report. National Evaluation Team for Breast cancer screening (NETB), Rotterdam.
  • Ghana Statistical Service (2010) Population Structure and demography. http://www.statsghana.gov.gh/. (accessed on 1 February 2011).
  • Ginsberg G, Lauer JA, Zelle S, Baeten S & Baltussen R (2012) Cost, effects and cost-effectiveness of strategies to combat breast, cervical and colorectal cancer in developing countries: a mathematical modelling study. BMJ 344, e614.
  • Greene FL, Compton CC, Fritz AG & Al E (2006) AJCC Cancer Staging Atlas Springer Inc., New York, NY.
  • Groot MT, Baltussen R, Uyl-De Groot CA, Anderson BO & Hortobagyi GN (2006) Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia. The Breast Journal 12(Suppl 1), S81S90.
  • Harford JB, Otero IV, Anderson BO et al. (2011) Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative. Breast 20(Suppl 2), S20S29.
  • Hortobagyi GN (2002) Novel approaches to the management of bone metastases in patients with breast cancer. Seminars in Oncology 29, 134144.
  • IARC (2008) World Cancer Report 2008. http://www.iarc.fr/en/publications/pdfs-online/wcr/ (accessed on 15 April 2011).
  • Khan SA, Stewart AK & Morrow M (2002) Does aggressive local therapy improve survival in metastatic breast cancer? Surgery 132, 620626; discussion 626–627.
  • Kumar SK (2007) Kerala, India: a regional community-based palliative care model. Journal of Pain and Symptom Management 33, 623627.
  • Lauer JA, Rohrich K, Wirth H et al. (2003) PopMod: a longitudinal population model with two interacting disease states. Cost Effectiveness and Resource Allocation 1, 6.
  • Miller AB (2008) Practical Applications for Clinical Breast Examination (CBE) and Breast Self-Examination (BSE) in Screening and Early Detection of Breast Cancer. Breast Care (Basel) 3, 1720.
  • Miller AB, To T, Baines CJ & Wall C (1997) The Canadian National Breast Screening Study: update on breast cancer mortality. Journal of the National Cancer Institute. Monographs 3, 741.
  • Mittra I, Mishra GA, Singh S et al. (2010) A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. International Journal of Cancer 126, 976984.
  • Mushlin AI, Kouides RW & Shapiro DE (1998) Estimating the accuracy of screening mammography: a meta-analysis. American Journal of Preventive Medicine 14, 143153.
  • National Health Insurance Authority (2010) Annual Report. Accra: National Health Insurance Scheme. http://www.nhis.gov.gh/_Uploads/dbsAttachedFiles/8(1).pdf (accessed on January 30 2012).
  • Oestreicher N, White E, Lehman CD et al. (2002) Predictors of sensitivity of clinical breast examination (CBE). Breast Cancer Research and Treatment 76, 7381.
  • Ohene-Yeboah M (2008) Breast pain in Ghanaian women: clinical, ultrasonographic, mammographic and histological findings in 1612 consecutive patients. West African Journal of Medicine 27, 2023.
  • Okonkwo QL, Draisma G, Der Kinderen A, Brown ML & De Koning HJ (2008) Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. Journal of the National Cancer Institute 100, 12901300.
  • Parkin DM, Sitas F, Chirenje M et al. (2008) Part I: cancer in Indigenous Africans – burden, distribution, and trends. The Lancet Oncology 9, 683692.
  • Pisani P, Parkin DM, Ngelangel C et al. (2006) Outcome of screening by clinical examination of the breast in a trial in the Philippines. International Journal of Cancer 118, 149154.
  • Radice D & Redaelli A (2003) Breast cancer management: quality-of-life and cost considerations. Pharmacoeconomics 21, 383396.
  • Shulman LN, Willett W, Sievers A & Knaul FM (2010) Breast cancer in developing countries: opportunities for improved survival. Journal of Oncology 2010, 595167.
  • Thomas DB, Gao DL, Ray RM et al. (2002) Randomized trial of breast self-examination in Shanghai: final results. Journal of the National Cancer Institute 94, 14451457.
  • Walsh D & Rybicki L (2006) Symptom clustering in advanced cancer. Supportive Care in Cancer 14, 831836.
  • WHO (2008) Global Burden of Disease 2004 update. http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html (accessed on 20 June 2011).
  • WHO (2010) World Health Statistics. http://www.who.int/whosis/whostat/en/index.html (accessed on 10 November 2010).
  • WHO (2011a) Choosing interventions that are cost effective. http://www.who.int/choice/en (accessed on 1 February 2011).
  • WHO (2011b) Department of Chronic Diseases and Health Promotion (CHP). http://www.who.int/cancer/palliative/en/ (accessed on 1 February 2011).
  • WHO Commission on Macroeconomics and Health (2011) Macroeconomics and health: investing in health for economic development. Report of the Commission on Macroeconomics and Health. http://whqlibdoc.who.int/publications/2001/924154550x.pdf (accessed on 20 June 2011).
  • WHO Department of Essential Health Technologies (2005) Essential Health Care Technology Package (EHTP). http://www.who.int/medical_devices/appropriate_use/en/ (accessed on 15 May 2010).
  • Wiredu EK & Armah HB (2006) Cancer mortality patterns in Ghana: a 10-year review of autopsies and hospital mortality. BMC Public Health 6, 159.
  • Zotov V & Shyyan R (2003) Introduction of breast cancer screening in Chernihiv Oblast in the Ukraine: report of a PATH Breast Cancer Assistance Program experience. The Breast Journal 9(Suppl 2), S75S80.